Clinical Trial Update: A Study of AK130 in Combination With AK112 for the Treatment of Advanced Biliary Tract Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update describing a Phase 1/Phase 2 study of AK130 in combination with AK112 for advanced biliary tract cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma

Drugs mentioned

• AK112
• AK130

Snippet

Sponsor: Akeso | Conditions: Biliary Tract Cancer | Phase 1, Phase 2 | Status: RECRUITING